In the fight against cancer, one form of the disease has flown under the radar for years despite the fact it is the fourth largest cause of cancer mortality among Americans: pancreatic cancer. This November, the largest U.S. retailer of mattresses, Mattress Firm is hoping to raise visibility around the disease as it recognizes National Pancreatic Cancer Awareness Month and makes a commitment to raise $1 million through the Mattress Firm Foundation. These funds will directly impact earlier detection and treatment of the disease.
Pancreatic cancer, which kills approximately 40,000 U.S. residents each year, is frequently referred to as a “silent killer” because it is challenging to detect at early stages, and when found, is difficult to treat. The $1 million commitment from the Mattress Firm Foundation will directly fund a research study on new imaging methods that may allow for earlier and more accurate detection of pancreatic cancer, before it spreads to other organs.
“As a national company with a footprint of more than 1,700 stores, we at Mattress Firm hope to help raise awareness of this deadly and complex disease,” said Steve Stagner, president and CEO of Mattress Firm. “Many of our team members have been personally touched by the disease and lost loved ones, and we dream it’s possible to extend the lives of our friends and loved ones through our funding and awareness-building programs. It used to be that only four percent of people with pancreatic cancer would live to survive another birthday. Now, thanks to clinical trials, 40 percent are living to see another year.”
Mattress Firm is partnering in the fight against pancreatic cancer with Scottsdale, Ariz.-based Translational Genomics Research Institute (TGen). TGen is a non-profit organization that focuses on developing earlier diagnostics and treatments of diseases, including pancreatic cancer.
Mattress Firm began its partnership with TGen in 2011 to help fund the institute’s aggressive search for the cure for pancreatic cancer. TGen’s cancer expert Dr. Daniel Von Hoff and his recent clinical trials have been instrumental in improving the one-year survival rate for patients diagnosed with the disease. Dr. Daniel Von Hoff is a distinguished professor and Physician-In-Chief and considered one of the world’s leading experts on pancreatic cancer. He has been instrumental in improving the survival rate for patients diagnosed with the disease.
This November, Mattress Firm is asking its customers to donate to the cause through a “Round Up” for pancreatic cancer fundraiser at point of purchase. By rounding a purchase up to the nearest dollar, ten dollars or even hundred dollars, each sale will directly benefit the Mattress Firm Foundation’s support of TGen’s clinical trials.
“For every $1 million raised, we can fund an additional clinical trial,” said Stagner. “Each trial brings us closer to finding a cure. Together, we can dream it’s possible to make this a reality in our lifetime.”
Mattress Firm stores across the country will also participate in local runs/walks and other fundraising events in their communities. Last year, more than 1,000 stores and 2,000 employees participated in local events in November alone.
For more information, visit www.mattressfirm.com.
About Mattress Firm: With more than 1,700 company-operated and franchised stores across 36 states, Mattress Firm has the largest geographic footprint in the United States among multi-brand mattress retailers. Founded in 1986, Houston-based Mattress Firm is the nation’s leading bedding retailer with more than $1.2 billion in sales for 2013. The company offers a broad selection of both traditional and specialty mattresses, bedding accessories and other related products from leading manufacturers, including Sealy, Tempur-Pedic, Serta, Simmons, Stearns & Foster, Hampton & Rhodes and Atmos. Mattress Firm guarantees price, comfort and service with the ultimate goal of ensuring customers Save Money. Sleep Happy™.